BR100 Increased By (0.08%)
BR30 Decreased By (-0.19%)
KSE100 Decreased By (-0.24%)
KSE30 Decreased By (-0.47%)
BECO 5.88 Decreased By ▼ -0.15 (-2.49%)
BML 58.03 Increased By ▲ 5.28 (10.01%)
BOP 33.80 Decreased By ▼ -0.45 (-1.31%)
CNERGY 8.16 No Change ▼ 0.00 (0%)
DCL 11.85 Decreased By ▼ -0.49 (-3.97%)
FCCL 53.76 Decreased By ▼ -0.13 (-0.24%)
FCSC 5.55 Increased By ▲ 0.33 (6.32%)
FFL 17.86 Decreased By ▼ -0.17 (-0.94%)
FNEL 1.31 Increased By ▲ 0.01 (0.77%)
HUMNL 11.15 Increased By ▲ 0.15 (1.36%)
KEL 8.09 Decreased By ▼ -0.02 (-0.25%)
KOSM 5.46 Increased By ▲ 0.08 (1.49%)
MLCF 88.30 Increased By ▲ 0.25 (0.28%)
NBP 183.55 Decreased By ▼ -2.93 (-1.57%)
PACE 11.79 Increased By ▲ 1.07 (9.98%)
PAEL 40.30 Increased By ▲ 0.36 (0.9%)
PIAHCLA 26.20 Increased By ▲ 0.03 (0.11%)
PIBTL 17.26 Decreased By ▼ -0.06 (-0.35%)
PPL 231.69 Decreased By ▼ -1.09 (-0.47%)
PRL 34.49 Decreased By ▼ -0.46 (-1.32%)
PTC 67.70 Increased By ▲ 0.14 (0.21%)
SEARL 91.30 Increased By ▲ 0.37 (0.41%)
SSGC 26.95 Decreased By ▼ -0.22 (-0.81%)
TELE 8.59 Increased By ▲ 0.02 (0.23%)
THCCL 65.01 Increased By ▲ 4.88 (8.12%)
TPLP 9.43 Increased By ▲ 0.67 (7.65%)
TREET 24.61 Increased By ▲ 0.07 (0.29%)
TRG 71.84 Increased By ▲ 0.09 (0.13%)
WAVES 10.98 Increased By ▲ 1.00 (10.02%)
WTL 1.27 Increased By ▲ 0.01 (0.79%)
By

GENEVA: The World Health Organization's vaccine advisers on Monday recommended people with weaker immune systems should be offered an additional dose of all authorised Covid-19 vaccines.

The UN health agency's Strategic Advisory Group of Experts on Immunisation (SAGE) also said over-60s who have been fully immunised with China's Sinovac and Sinopharm vaccine should be offered an additional third Covid-19 vaccine dose.

The experts stressed they were not recommending an additional so-called booster dose for the population at large.

Several Covid-19 vaccines have been given WHO approval for emergency use during the pandemic: Pfizer-BioNTech, Janssen, Moderna, Sinopharm, Sinovac and AstraZeneca.

AstraZeneca antibody drug important as preventative COVID-19 therapy

It is on the verge of deciding whether to give emergency use listing to India's Bharat Biotech jab.

SAGE held a four-day meeting last week to review the latest information and data on a range of vaccines for Covid-19 and other diseases.

"SAGE recommended that moderately and severely immunocompromised persons should be offered an additional dose of all WHO EUL (emergency use listing) Covid-19 vaccines as part of an extended primary series," the group said.

"These individuals are less likely to respond adequately to vaccination following a standard primary vaccine series and are at high risk of severe Covid-19 disease."

It also said that for people fully immunised with Sinovac and Sinopharm vaccines, an additional third dose of the same jab "should be offered to persons aged 60 and above".

A different vaccine "may also be considered based on vaccine supply and access considerations".

SAGE added that when implementing this recommendation, countries should initially aim at maximising two-dose coverage in that population, and thereafter administer the third dose, starting in the oldest age groups.

Comments

Comments are closed for this article.